Search
Advanced search
Filter by category
Filter by committee
Search results
-
ASTM International and the Parenteral Drug Association recently signed a Memorandum of Understanding that launches a pilot to streamline efforts and conserve resources as both organizations develop technical guidance for the pharmaceutical industry. Katharine Morgan, executive vice president, ASTM, and Richard M. Johnson, president, PDA, signed the MOU. “The MOU between ASTM International and PDA…, ASTM Committee E55 on Manufacture of Pharmaceutical Products Next Meeting:, April 28-30, 2015, Lisbon, Portugal, Media Inquiries:, Nathan Osburn, tel +1.610.832.9603; nosburn@astm.org, ASTM Staff Contact:, Christine DeJong, tel +1.610.832.9736; cdejong@astm.org Release #9815 ###
-
Activated carbon is processed to have small, low-volume pores that increase the surface area available for adsorption. It has applications in the medical, environmental and energy realms, among others. Since 1962, ASTM International Committee D28 on Activated Carbon has developed standards that play a pre-eminent role in how activated carbon is used. A D28 subcommittee, D28.02 on Liquid Phase…, WK47401, Xylenol Orange Dye, The xylenol orange dye test is a way to determine the relative adsorption rate of unused or reactivated carbons by adsorption of xylenol orange from aqueous solution. This is an important means for deciding which type of activated carbon to use to a specific water treatment application. “Activated carbon performance can roughly be defined as a combination of the ability to adsorb a particular…, WK47421, Particle Size Distribution, Mercury flue gas, home water filters and potable water treatment are the main applications in which powdered and fine mesh carbons are used. A proposed new test method will describe how a laser light scattering technique can determine the particle size distribution of fine mesh activated carbon. ASTM member Neal Megonnell, vice president, sales and marketing, Haycarb USA, says the proposed test…, ASTM Committee D28 Next Meeting:, April 27, April Committee Week, Anaheim, Calif., Technical Contact:, (WK47401) Adam Redding, Ph.D., Evoqua Water Technologies LLC, Northwest, Pa., tel +1.724.719.0805; adam.redding@evoqua.com and (WK47421) Neal E. Megonnell, Haycarb USA, Pittsburgh, Pa., tel +1.412.709.7487; neal@haycarbusa.com, ASTM Staff Contact:, Kelly Paul, tel +1.610.832.9745; kpaul@astm.org, ASTM PR Contact:, Barbara Schindler, tel +1.610.832.9603; bschindl@astm.org Release #9731
-
ASTM International Committee E55 on Manufacture of Pharmaceutical Products is currently developing a proposed standard that will document a set of process steps that can reproducibly inactivate or remove any potential retrovirus in new biological products, particularly antibodies and antibody-like compounds. The proposed standard, ASTM WK39883 , Practice for Process of Inactivation of Enveloped…, ASTM Committee E55 Next Meeting:, April 9-11, 2013, Genzyme-A Sanofi Company, Haverhill, Suffolk, United Kingdom, Technical Contact:, John Schreffler, Ph.D., Morphotek Inc., Exton, Pa., Phone: 610-423-6557; jschreffler@morphotek.com, ASTM Staff Contact:, Christine DeJong, Phone: 610-832-9736; cdejong@astm.org, ASTM PR Contact:, Barbara Schindler, Phone: 610-832-9603; bschindl@astm.org Release #9327
-
A proposed new ASTM International standard will provide an important process step to be used in the manufacture of protein-based drugs, such as antibodies and fusion proteins, made to inactivate retroviruses. The proposed standard, ASTM WK36552 , Practice for Inactivation of Retrovirus by pH, is being developed by Subcommittee E55.04 on General Biopharmaceutical Standards , part of ASTM…
-
Mercury emissions from flue gases in coal-fired power plants are a large source of atmospheric mercury in the United States, but no standard for determination of mercury adsorption currently exists. One promising method of controlling these emissions involves the injection of powdered activated carbon into the flue gas. A proposed new ASTM International standard would evaluate the performance of…
-
While the continuous quality verification concept is still quite new, it has the potential to become an important approach to assuring product quality in the pharmaceutical industry. With this in mind, ASTM International Committee E55 on Manufacture of Pharmaceutical Products has approved a new standard, E2537 , Guide for Application of Continuous Quality Verification to Pharmaceutical and…
-
ASTM International Committee E55 on Manufacture of Pharmaceutical Products has developed a new standard that covers the life cycle of pharmaceutical and biopharmaceutical manufacturing systems. The new standard, E 2500 , Guide for Specification, Design and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment, is under the jurisdiction of Subcommittee E55.03 on…
-
The ASTM International committee formerly known as E55 on Pharmaceutical Application of Process Analytical Technology has undergone a change in title and scope that reflects the intent of the committee to be more inclusive of all the tools, instrumentation and sciences that might be used by the industry in the management of pharmaceutical manufacturing processes. The committee is now known as E55…
-
ASTM International Committee E55 on Pharmaceutical Application of Process Analytical Technology has now approved its first practice. ASTM E 2474 , Practice for Pharmaceutical Process Design Utilizing Processing Analytical Technology, is under the jurisdiction of Subcommittee E55.02 on PAT System Implementation and Practice. Practice E 2474 covers process design, which is integral to process…
-
ASTM International Committee E55 on Pharmaceutical Application of Process Analytical Technology has created a new subcommittee, E55.03 on General Pharmaceutical Standards, which will address issues on quality within a broad framework of chemistry, manufacturing and control. The scope of the new subcommittee is the development of general principles, practices and related standards for managing…